

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.03866237 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.37665035 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.32783353 |
| 4 | sphingoid metabolic process (GO:0046519) | 4.30481980 |
| 5 | negative regulation of hormone metabolic process (GO:0032351) | 4.06087538 |
| 6 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.06087538 |
| 7 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.01894601 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.00092546 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.93440159 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.93440159 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.93440159 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.93440159 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.93440159 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.93440159 |
| 15 | sphingosine metabolic process (GO:0006670) | 3.89351989 |
| 16 | platelet dense granule organization (GO:0060155) | 3.85159504 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.84961586 |
| 18 | gamma-aminobutyric acid transport (GO:0015812) | 3.83669371 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.81090919 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 3.79895386 |
| 21 | sodium ion export (GO:0071436) | 3.79599727 |
| 22 | DNA deamination (GO:0045006) | 3.76317957 |
| 23 | adaptation of signaling pathway (GO:0023058) | 3.73650171 |
| 24 | desmosome organization (GO:0002934) | 3.72580313 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.63195161 |
| 26 | regulation of ARF protein signal transduction (GO:0032012) | 3.54764247 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53475551 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.47201053 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 3.41077688 |
| 30 | diol metabolic process (GO:0034311) | 3.39390186 |
| 31 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.38749559 |
| 32 | detection of light stimulus involved in visual perception (GO:0050908) | 3.38749559 |
| 33 | detection of bacterium (GO:0016045) | 3.30688074 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.29242885 |
| 35 | gonadal mesoderm development (GO:0007506) | 3.28929827 |
| 36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.27139336 |
| 37 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.24460628 |
| 38 | detection of other organism (GO:0098543) | 3.22592487 |
| 39 | positive regulation of vesicle fusion (GO:0031340) | 3.22552035 |
| 40 | fucose catabolic process (GO:0019317) | 3.21968015 |
| 41 | L-fucose metabolic process (GO:0042354) | 3.21968015 |
| 42 | L-fucose catabolic process (GO:0042355) | 3.21968015 |
| 43 | potassium ion homeostasis (GO:0055075) | 3.18480485 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.16160729 |
| 45 | negative regulation of mast cell activation (GO:0033004) | 3.14220790 |
| 46 | potassium ion import (GO:0010107) | 3.10651874 |
| 47 | vesicle transport along microtubule (GO:0047496) | 3.07624278 |
| 48 | locomotory exploration behavior (GO:0035641) | 3.02696974 |
| 49 | cellular response to ATP (GO:0071318) | 3.00964600 |
| 50 | negative regulation of telomere maintenance (GO:0032205) | 2.97844849 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 2.97388382 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 2.97388382 |
| 53 | tryptophan catabolic process (GO:0006569) | 2.97388382 |
| 54 | vocalization behavior (GO:0071625) | 2.97219445 |
| 55 | modulation by symbiont of host cellular process (GO:0044068) | 2.94324984 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 2.94238565 |
| 57 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92712735 |
| 58 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.89724933 |
| 59 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.89230284 |
| 60 | synaptic vesicle exocytosis (GO:0016079) | 2.88606774 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 2.85088629 |
| 62 | glutamate receptor signaling pathway (GO:0007215) | 2.84528567 |
| 63 | positive regulation of receptor recycling (GO:0001921) | 2.82999229 |
| 64 | low-density lipoprotein particle clearance (GO:0034383) | 2.82482332 |
| 65 | neuromuscular process controlling balance (GO:0050885) | 2.82285634 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.82254736 |
| 67 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.80921882 |
| 68 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.78590313 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 2.77269282 |
| 70 | response to pheromone (GO:0019236) | 2.76486422 |
| 71 | negative regulation of adenylate cyclase activity (GO:0007194) | 2.75341100 |
| 72 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.74137834 |
| 73 | neuronal action potential (GO:0019228) | 2.73366533 |
| 74 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.73294695 |
| 75 | transmission of nerve impulse (GO:0019226) | 2.72348880 |
| 76 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.71239288 |
| 77 | respiratory chain complex IV assembly (GO:0008535) | 2.68831230 |
| 78 | synaptic transmission, cholinergic (GO:0007271) | 2.68724998 |
| 79 | neuronal action potential propagation (GO:0019227) | 2.67591649 |
| 80 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.66749816 |
| 81 | behavioral response to ethanol (GO:0048149) | 2.66261857 |
| 82 | axoneme assembly (GO:0035082) | 2.66006383 |
| 83 | positive regulation of fibroblast migration (GO:0010763) | 2.65211111 |
| 84 | prepulse inhibition (GO:0060134) | 2.65027164 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.64991616 |
| 86 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.64735433 |
| 87 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.64735433 |
| 88 | negative regulation of amino acid transport (GO:0051956) | 2.64005489 |
| 89 | membrane depolarization during action potential (GO:0086010) | 2.63271977 |
| 90 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.62469587 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62040879 |
| 92 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.62026682 |
| 93 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.59719780 |
| 94 | nerve growth factor signaling pathway (GO:0038180) | 2.59209536 |
| 95 | kynurenine metabolic process (GO:0070189) | 2.58107718 |
| 96 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.57983749 |
| 97 | membrane hyperpolarization (GO:0060081) | 2.57396268 |
| 98 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.56823996 |
| 99 | cytochrome complex assembly (GO:0017004) | 2.56779424 |
| 100 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.56706793 |
| 101 | negative regulation of cyclase activity (GO:0031280) | 2.56573322 |
| 102 | adult walking behavior (GO:0007628) | 2.54864354 |
| 103 | protein localization to cilium (GO:0061512) | 2.54231160 |
| 104 | anterograde synaptic vesicle transport (GO:0048490) | 2.54080653 |
| 105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.53139705 |
| 106 | dendrite morphogenesis (GO:0048813) | 2.53027926 |
| 107 | L-amino acid import (GO:0043092) | 2.52630744 |
| 108 | piRNA metabolic process (GO:0034587) | 2.49365221 |
| 109 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.49200628 |
| 110 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.48979476 |
| 111 | macroautophagy (GO:0016236) | 2.48978303 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.48928367 |
| 113 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.48649059 |
| 114 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.47798006 |
| 115 | dopamine receptor signaling pathway (GO:0007212) | 2.47100588 |
| 116 | regulation of action potential (GO:0098900) | 2.46644474 |
| 117 | long-term memory (GO:0007616) | 2.45926429 |
| 118 | regulation of synaptic vesicle transport (GO:1902803) | 2.45666916 |
| 119 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.45446585 |
| 120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45375696 |
| 121 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45340466 |
| 122 | positive regulation of neurotransmitter transport (GO:0051590) | 2.44890316 |
| 123 | regulation of acrosome reaction (GO:0060046) | 2.44566659 |
| 124 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.43213282 |
| 125 | glycine transport (GO:0015816) | 2.43081348 |
| 126 | regulation of vesicle fusion (GO:0031338) | 2.42117848 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 2.42099281 |
| 128 | axonal fasciculation (GO:0007413) | 2.41721091 |
| 129 | modulation by virus of host process (GO:0019054) | 2.41572804 |
| 130 | cellular sodium ion homeostasis (GO:0006883) | 2.41542804 |
| 131 | mannosylation (GO:0097502) | 2.41484172 |
| 132 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40181326 |
| 133 | negative regulation of cAMP metabolic process (GO:0030815) | 2.39117045 |
| 134 | regulation of Rap GTPase activity (GO:0032317) | 2.38986219 |
| 135 | regulation of neuron projection regeneration (GO:0070570) | 2.38831875 |
| 136 | regulation of axon regeneration (GO:0048679) | 2.38831875 |
| 137 | cAMP catabolic process (GO:0006198) | 2.38552106 |
| 138 | epithelial cilium movement (GO:0003351) | 2.37371322 |
| 139 | tryptophan metabolic process (GO:0006568) | 2.36993032 |
| 140 | auditory behavior (GO:0031223) | 2.36465688 |
| 141 | calcium ion import (GO:0070509) | 2.35998303 |
| 142 | indole-containing compound metabolic process (GO:0042430) | 2.35236590 |
| 143 | positive regulation of fatty acid transport (GO:2000193) | 2.33919258 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.33469214 |
| 145 | C4-dicarboxylate transport (GO:0015740) | 2.32611380 |
| 146 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.32603137 |
| 147 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.32248670 |
| 148 | regulation of Rac GTPase activity (GO:0032314) | 2.32241078 |
| 149 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.32133683 |
| 150 | striatum development (GO:0021756) | 2.32008231 |
| 151 | positive regulation of prostaglandin secretion (GO:0032308) | 2.29509306 |
| 152 | mitotic cell cycle arrest (GO:0071850) | 2.27935440 |
| 153 | photoreceptor cell maintenance (GO:0045494) | 2.27741532 |
| 154 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.25466674 |
| 155 | negative regulation of interleukin-1 production (GO:0032692) | 2.24047938 |
| 156 | multicellular organism reproduction (GO:0032504) | 2.23856786 |
| 157 | regulation of neurotransmitter uptake (GO:0051580) | 2.23015132 |
| 158 | amine catabolic process (GO:0009310) | 2.22912224 |
| 159 | cellular biogenic amine catabolic process (GO:0042402) | 2.22912224 |
| 160 | proline transport (GO:0015824) | 2.22740335 |
| 161 | interferon-gamma production (GO:0032609) | 2.22276019 |
| 162 | positive regulation of organic acid transport (GO:0032892) | 2.20493105 |
| 163 | auditory receptor cell stereocilium organization (GO:0060088) | 2.19731389 |
| 164 | retinal cone cell development (GO:0046549) | 2.19088747 |
| 165 | startle response (GO:0001964) | 2.17756937 |
| 166 | urinary tract smooth muscle contraction (GO:0014848) | 2.14851236 |
| 167 | microglial cell activation (GO:0001774) | 2.14520146 |
| 168 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.14095771 |
| 169 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.13562722 |
| 170 | regulation of mesoderm development (GO:2000380) | 2.13220126 |
| 171 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.12955973 |
| 172 | positive regulation of defense response to virus by host (GO:0002230) | 2.12925098 |
| 173 | cytidine metabolic process (GO:0046087) | 2.12873929 |
| 174 | cytidine catabolic process (GO:0006216) | 2.12873929 |
| 175 | cytidine deamination (GO:0009972) | 2.12873929 |
| 176 | ovulation cycle (GO:0042698) | 2.12211422 |
| 177 | cilium movement (GO:0003341) | 2.11326647 |
| 178 | regulation of cilium movement (GO:0003352) | 2.10604491 |
| 179 | glycosphingolipid biosynthetic process (GO:0006688) | 2.10476218 |
| 180 | activated T cell proliferation (GO:0050798) | 2.10193727 |
| 181 | cyclic nucleotide catabolic process (GO:0009214) | 2.10163154 |
| 182 | positive regulation of heat generation (GO:0031652) | 2.10084794 |
| 183 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.09547456 |
| 184 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.05223098 |
| 185 | opioid receptor signaling pathway (GO:0038003) | 2.04360062 |
| 186 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.04018095 |
| 187 | protein polyglutamylation (GO:0018095) | 2.03355428 |
| 188 | NAD biosynthetic process (GO:0009435) | 2.02727802 |
| 189 | photoreceptor cell development (GO:0042461) | 2.02465408 |
| 190 | positive regulation of amino acid transport (GO:0051957) | 2.01099774 |
| 191 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.00619434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.88727350 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.09962637 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.98268541 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.85640194 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.58127255 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.56510288 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33204332 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27291529 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13548887 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05044851 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02980829 |
| 12 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.99641163 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99554428 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98295583 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85127216 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84787245 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.81980897 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79490574 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78760438 |
| 20 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.76113314 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76083327 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71793821 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70100340 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69992417 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65039073 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64390841 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.62847664 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62724216 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62724216 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60576847 |
| 31 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.59694265 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59694265 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56909837 |
| 34 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.52951300 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52367228 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51570332 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51322388 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50261747 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49779654 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48801549 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48054721 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47477090 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47370053 |
| 44 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47180168 |
| 45 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46020637 |
| 46 | RXR_22108803_ChIP-Seq_LS180_Human | 1.45648875 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45549863 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44117501 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41159426 |
| 50 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37920673 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37852563 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36446141 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36377950 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36302132 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33713303 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33057640 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32358508 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31974137 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31839283 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31309048 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31144866 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30847109 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30782522 |
| 64 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.29065625 |
| 65 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28276034 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.27990850 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27474159 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26405218 |
| 69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25350088 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24506265 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24495823 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23890744 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23687135 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23485988 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23034863 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22699628 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22400627 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20306599 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20240585 |
| 80 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19923157 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19744779 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18753156 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17889839 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17889839 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17823992 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17823992 |
| 87 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15731360 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15646061 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14762704 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14128533 |
| 91 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13702181 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13702181 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12740807 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12429692 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11793741 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10981209 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10849834 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10059677 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09020577 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07749667 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07731683 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07578664 |
| 103 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07558329 |
| 104 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07338675 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06513782 |
| 106 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06501374 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05950719 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05006114 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04253302 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03969375 |
| 111 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03634543 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03158040 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02526172 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02475489 |
| 115 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02468040 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02453565 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02355628 |
| 118 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00881105 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99658071 |
| 120 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99453507 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98916348 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98706847 |
| 123 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98451309 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98302640 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98286748 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97794396 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97562584 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97433029 |
| 129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97251889 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96690015 |
| 131 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96366162 |
| 132 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96237587 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96199593 |
| 134 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96063483 |
| 135 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95697766 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94778772 |
| 137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94738610 |
| 138 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94438104 |
| 139 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.93258169 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93010406 |
| 141 | AR_19668381_ChIP-Seq_PC3_Human | 0.92842804 |
| 142 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92308013 |
| 143 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92042837 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91514886 |
| 145 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91385136 |
| 146 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90614509 |
| 147 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90587983 |
| 148 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90246156 |
| 149 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90197157 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90171903 |
| 151 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89887931 |
| 152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89513261 |
| 153 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89372698 |
| 154 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86374608 |
| 155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86028566 |
| 156 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85808467 |
| 157 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85499234 |
| 158 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84839052 |
| 159 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83333041 |
| 160 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83158749 |
| 161 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82573252 |
| 162 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82573201 |
| 163 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81543921 |
| 164 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81406096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.92314676 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.38741025 |
| 3 | MP0003880_abnormal_central_pattern | 4.06617659 |
| 4 | MP0010386_abnormal_urinary_bladder | 3.96851100 |
| 5 | MP0002822_catalepsy | 3.11991261 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.92764635 |
| 7 | MP0002102_abnormal_ear_morphology | 2.86826346 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.71245767 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.47918403 |
| 10 | MP0009745_abnormal_behavioral_response | 2.27627121 |
| 11 | MP0000604_amyloidosis | 2.25182273 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.22294724 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.21601507 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.20877537 |
| 15 | MP0002736_abnormal_nociception_after | 2.12483922 |
| 16 | MP0002064_seizures | 2.11481586 |
| 17 | MP0003303_peritoneal_inflammation | 2.06415894 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.06224090 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.04537151 |
| 20 | MP0002796_impaired_skin_barrier | 2.02476160 |
| 21 | MP0005671_abnormal_response_to | 2.02275488 |
| 22 | MP0009046_muscle_twitch | 2.01783788 |
| 23 | MP0002254_reproductive_system_inflammat | 2.01445611 |
| 24 | MP0004947_skin_inflammation | 1.96502753 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.96014671 |
| 26 | MP0004742_abnormal_vestibular_system | 1.94183157 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.87517463 |
| 28 | MP0003195_calcinosis | 1.81487849 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.81413445 |
| 30 | MP0003075_altered_response_to | 1.76640742 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.75771535 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.74341067 |
| 33 | MP0004510_myositis | 1.73449773 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.72776929 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.70608676 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.66946542 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.66218736 |
| 38 | MP0003724_increased_susceptibility_to | 1.66080471 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.59906305 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59803068 |
| 41 | MP0004858_abnormal_nervous_system | 1.56778420 |
| 42 | MP0004270_analgesia | 1.55228682 |
| 43 | MP0003690_abnormal_glial_cell | 1.52900620 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.51904215 |
| 45 | MP0001486_abnormal_startle_reflex | 1.51087429 |
| 46 | MP0004142_abnormal_muscle_tone | 1.50749330 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.50705156 |
| 48 | MP0008872_abnormal_physiological_respon | 1.47207269 |
| 49 | MP0002234_abnormal_pharynx_morphology | 1.44723223 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.44685641 |
| 51 | MP0002272_abnormal_nervous_system | 1.44226232 |
| 52 | MP0001905_abnormal_dopamine_level | 1.44110046 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.44109579 |
| 54 | MP0008874_decreased_physiological_sensi | 1.43851660 |
| 55 | MP0005310_abnormal_salivary_gland | 1.42464169 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.40846252 |
| 57 | MP0004043_abnormal_pH_regulation | 1.40831630 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.36334470 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.36171146 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.34883157 |
| 61 | MP0003878_abnormal_ear_physiology | 1.34883157 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.34651174 |
| 63 | MP0003329_amyloid_beta_deposits | 1.34200920 |
| 64 | MP0005253_abnormal_eye_physiology | 1.33575927 |
| 65 | MP0002733_abnormal_thermal_nociception | 1.32004015 |
| 66 | MP0001970_abnormal_pain_threshold | 1.30716364 |
| 67 | MP0002735_abnormal_chemical_nociception | 1.28589542 |
| 68 | MP0003136_yellow_coat_color | 1.28556864 |
| 69 | MP0003436_decreased_susceptibility_to | 1.27278501 |
| 70 | MP0004130_abnormal_muscle_cell | 1.26698655 |
| 71 | MP0003787_abnormal_imprinting | 1.25103782 |
| 72 | MP0001485_abnormal_pinna_reflex | 1.24545318 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.22340874 |
| 74 | MP0000516_abnormal_urinary_system | 1.22340874 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.21967158 |
| 76 | MP0009840_abnormal_foam_cell | 1.20824059 |
| 77 | MP0000685_abnormal_immune_system | 1.20507166 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.20013570 |
| 79 | MP0005387_immune_system_phenotype | 1.19720050 |
| 80 | MP0001790_abnormal_immune_system | 1.19720050 |
| 81 | MP0003283_abnormal_digestive_organ | 1.18729730 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.18127907 |
| 83 | MP0005646_abnormal_pituitary_gland | 1.17957978 |
| 84 | MP0002067_abnormal_sensory_capabilities | 1.17759424 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.13851288 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 1.12769846 |
| 87 | MP0003879_abnormal_hair_cell | 1.11682258 |
| 88 | MP0009764_decreased_sensitivity_to | 1.10627932 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 1.10624822 |
| 90 | MP0004133_heterotaxia | 1.07818047 |
| 91 | MP0003646_muscle_fatigue | 1.07698157 |
| 92 | MP0004885_abnormal_endolymph | 1.07049334 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 1.06924158 |
| 94 | MP0004811_abnormal_neuron_physiology | 1.06700253 |
| 95 | MP0006292_abnormal_olfactory_placode | 1.06612559 |
| 96 | MP0003137_abnormal_impulse_conducting | 1.05467288 |
| 97 | MP0001851_eye_inflammation | 1.04984082 |
| 98 | MP0002090_abnormal_vision | 1.04015024 |
| 99 | MP0001800_abnormal_humoral_immune | 1.03767135 |
| 100 | MP0002928_abnormal_bile_duct | 1.01912138 |
| 101 | MP0002419_abnormal_innate_immunity | 1.01678574 |
| 102 | MP0003183_abnormal_peptide_metabolism | 1.01393321 |
| 103 | MP0008569_lethality_at_weaning | 1.00856959 |
| 104 | MP0003633_abnormal_nervous_system | 1.00140477 |
| 105 | MP0005166_decreased_susceptibility_to | 0.95140934 |
| 106 | MP0001984_abnormal_olfaction | 0.95029350 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.95007591 |
| 108 | MP0010771_integument_phenotype | 0.93986829 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.91683546 |
| 110 | MP0001177_atelectasis | 0.89545687 |
| 111 | MP0005448_abnormal_energy_balance | 0.88667641 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.88616265 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.88236159 |
| 114 | MP0002723_abnormal_immune_serum | 0.87744788 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.87099537 |
| 116 | MP0005647_abnormal_sex_gland | 0.86263418 |
| 117 | MP0005535_abnormal_body_temperature | 0.85826252 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.85035338 |
| 119 | MP0008260_abnormal_autophagy | 0.84579761 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.84394824 |
| 121 | MP0006082_CNS_inflammation | 0.83758843 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.83695792 |
| 123 | MP0005275_abnormal_skin_tensile | 0.83472805 |
| 124 | MP0002229_neurodegeneration | 0.82535134 |
| 125 | MP0001873_stomach_inflammation | 0.82502344 |
| 126 | MP0004215_abnormal_myocardial_fiber | 0.81460307 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.81432911 |
| 128 | MP0002452_abnormal_antigen_presenting | 0.80412275 |
| 129 | MP0002933_joint_inflammation | 0.79362439 |
| 130 | MP0000026_abnormal_inner_ear | 0.79150883 |
| 131 | MP0003091_abnormal_cell_migration | 0.77673373 |
| 132 | MP0005423_abnormal_somatic_nervous | 0.77524763 |
| 133 | MP0010678_abnormal_skin_adnexa | 0.77443041 |
| 134 | MP0004924_abnormal_behavior | 0.77419179 |
| 135 | MP0005386_behavior/neurological_phenoty | 0.77419179 |
| 136 | MP0003631_nervous_system_phenotype | 0.77301351 |
| 137 | MP0000920_abnormal_myelination | 0.76231505 |
| 138 | MP0000955_abnormal_spinal_cord | 0.75076685 |
| 139 | MP0003632_abnormal_nervous_system | 0.74628552 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.74601991 |
| 141 | MP0003045_fibrosis | 0.71100921 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.70955643 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.69185711 |
| 144 | MP0003634_abnormal_glial_cell | 0.67186417 |
| 145 | MP0002882_abnormal_neuron_morphology | 0.66805261 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.66391627 |
| 147 | MP0001533_abnormal_skeleton_physiology | 0.66009262 |
| 148 | MP0005501_abnormal_skin_physiology | 0.65731790 |
| 149 | MP0004484_altered_response_of | 0.65430274 |
| 150 | MP0002184_abnormal_innervation | 0.65320324 |
| 151 | MP0002066_abnormal_motor_capabilities/c | 0.65009493 |
| 152 | MP0005076_abnormal_cell_differentiation | 0.62905246 |
| 153 | MP0003011_delayed_dark_adaptation | 0.62873978 |
| 154 | MP0005167_abnormal_blood-brain_barrier | 0.62626172 |
| 155 | MP0002837_dystrophic_cardiac_calcinosis | 0.62188001 |
| 156 | MP0005451_abnormal_body_composition | 0.60509367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.80767168 |
| 2 | Myokymia (HP:0002411) | 5.36330662 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.11516329 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 3.86635531 |
| 5 | Molar tooth sign on MRI (HP:0002419) | 3.85993672 |
| 6 | Abnormality of midbrain morphology (HP:0002418) | 3.85993672 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.79893977 |
| 8 | Pancreatic cysts (HP:0001737) | 3.79586399 |
| 9 | Focal seizures (HP:0007359) | 3.76598889 |
| 10 | Nephronophthisis (HP:0000090) | 3.65025853 |
| 11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.59319475 |
| 12 | Genetic anticipation (HP:0003743) | 3.52876779 |
| 13 | Hyperventilation (HP:0002883) | 3.51279830 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.49866268 |
| 15 | True hermaphroditism (HP:0010459) | 3.45492611 |
| 16 | Parakeratosis (HP:0001036) | 3.40207835 |
| 17 | Long toe (HP:0010511) | 3.37242378 |
| 18 | Global brain atrophy (HP:0002283) | 3.33280930 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.32540452 |
| 20 | Abnormality of binocular vision (HP:0011514) | 3.27269955 |
| 21 | Diplopia (HP:0000651) | 3.27269955 |
| 22 | Visual hallucinations (HP:0002367) | 3.24758142 |
| 23 | Hemiplegia (HP:0002301) | 3.23544344 |
| 24 | Abnormality of the renal medulla (HP:0100957) | 3.14143917 |
| 25 | Febrile seizures (HP:0002373) | 3.10117200 |
| 26 | Mutism (HP:0002300) | 3.09502957 |
| 27 | Decreased central vision (HP:0007663) | 3.07354548 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 2.98080118 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97022071 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96007562 |
| 31 | Type II lissencephaly (HP:0007260) | 2.93549902 |
| 32 | Attenuation of retinal blood vessels (HP:0007843) | 2.92741918 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.85764060 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 2.82126917 |
| 35 | Absent/shortened dynein arms (HP:0200106) | 2.81968527 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.81968527 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.78357471 |
| 38 | Action tremor (HP:0002345) | 2.77174948 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.76887064 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.75773220 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 2.71354521 |
| 42 | Tubular atrophy (HP:0000092) | 2.69798930 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.69349688 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.69349688 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.69349688 |
| 46 | Axonal loss (HP:0003447) | 2.69097023 |
| 47 | Stomatitis (HP:0010280) | 2.67875048 |
| 48 | Neuronal loss in central nervous system (HP:0002529) | 2.67561506 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.64994438 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.62835910 |
| 51 | Abnormal drinking behavior (HP:0030082) | 2.62376200 |
| 52 | Polydipsia (HP:0001959) | 2.62376200 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61950627 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61950627 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61950627 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.59911951 |
| 57 | Absent speech (HP:0001344) | 2.58051456 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.57702359 |
| 59 | Spastic tetraparesis (HP:0001285) | 2.54769982 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54452244 |
| 61 | Postural instability (HP:0002172) | 2.53717045 |
| 62 | Lip pit (HP:0100267) | 2.52142919 |
| 63 | Dysmetric saccades (HP:0000641) | 2.51303324 |
| 64 | Amyloidosis (HP:0011034) | 2.51018307 |
| 65 | Neurofibrillary tangles (HP:0002185) | 2.46318415 |
| 66 | Akinesia (HP:0002304) | 2.43745341 |
| 67 | Disinhibition (HP:0000734) | 2.40279172 |
| 68 | Inability to walk (HP:0002540) | 2.39392082 |
| 69 | Decreased circulating renin level (HP:0003351) | 2.31596750 |
| 70 | Pendular nystagmus (HP:0012043) | 2.28937991 |
| 71 | Dysdiadochokinesis (HP:0002075) | 2.28289732 |
| 72 | Chronic sinusitis (HP:0011109) | 2.28183549 |
| 73 | Chronic otitis media (HP:0000389) | 2.28020267 |
| 74 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25485763 |
| 75 | Clumsiness (HP:0002312) | 2.24882732 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.24211467 |
| 77 | Gait imbalance (HP:0002141) | 2.24020858 |
| 78 | Abnormal ciliary motility (HP:0012262) | 2.23953155 |
| 79 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.22971349 |
| 80 | Aplasia of the phalanges of the hand (HP:0009802) | 2.22971349 |
| 81 | Aplasia involving bones of the extremities (HP:0009825) | 2.22971349 |
| 82 | Lower limb amyotrophy (HP:0007210) | 2.22354019 |
| 83 | Polyuria (HP:0000103) | 2.21869427 |
| 84 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.21483382 |
| 85 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.21483382 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.20762830 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20762830 |
| 88 | Dialeptic seizures (HP:0011146) | 2.19609562 |
| 89 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19552475 |
| 90 | Torticollis (HP:0000473) | 2.18873456 |
| 91 | Loss of speech (HP:0002371) | 2.18708798 |
| 92 | Rib fusion (HP:0000902) | 2.17735015 |
| 93 | Chronic hepatic failure (HP:0100626) | 2.17049261 |
| 94 | Large for gestational age (HP:0001520) | 2.15999448 |
| 95 | Stomach cancer (HP:0012126) | 2.15354954 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13851878 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.12659719 |
| 98 | Cystic liver disease (HP:0006706) | 2.12215556 |
| 99 | Progressive inability to walk (HP:0002505) | 2.10328241 |
| 100 | Anhidrosis (HP:0000970) | 2.09423410 |
| 101 | Intention tremor (HP:0002080) | 2.08559695 |
| 102 | Polyphagia (HP:0002591) | 2.06789566 |
| 103 | Protruding tongue (HP:0010808) | 2.06056929 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.03612005 |
| 105 | Urticaria (HP:0001025) | 2.03185475 |
| 106 | Gingivitis (HP:0000230) | 2.01454122 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01202949 |
| 108 | Hemiparesis (HP:0001269) | 2.00525194 |
| 109 | Impaired smooth pursuit (HP:0007772) | 2.00396890 |
| 110 | Impaired social interactions (HP:0000735) | 2.00110644 |
| 111 | Abnormal social behavior (HP:0012433) | 2.00110644 |
| 112 | Abnormality of the 2nd finger (HP:0004100) | 1.99788842 |
| 113 | Ankle clonus (HP:0011448) | 1.98998792 |
| 114 | Dysostosis multiplex (HP:0000943) | 1.98321698 |
| 115 | Distal lower limb amyotrophy (HP:0008944) | 1.98281492 |
| 116 | Sparse lateral eyebrow (HP:0005338) | 1.97164642 |
| 117 | Craniofacial dystonia (HP:0012179) | 1.96242030 |
| 118 | Dysmetria (HP:0001310) | 1.95613798 |
| 119 | Depression (HP:0000716) | 1.94468927 |
| 120 | Apathy (HP:0000741) | 1.94390403 |
| 121 | Tubulointerstitial fibrosis (HP:0005576) | 1.93643468 |
| 122 | Renal cortical cysts (HP:0000803) | 1.93626677 |
| 123 | Keratoconus (HP:0000563) | 1.93608497 |
| 124 | Increased corneal curvature (HP:0100692) | 1.93608497 |
| 125 | Epileptic encephalopathy (HP:0200134) | 1.92597435 |
| 126 | Focal dystonia (HP:0004373) | 1.92595702 |
| 127 | Broad-based gait (HP:0002136) | 1.92402891 |
| 128 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.92078606 |
| 129 | Retinal dysplasia (HP:0007973) | 1.91533167 |
| 130 | Palmoplantar hyperkeratosis (HP:0000972) | 1.90563797 |
| 131 | Sclerocornea (HP:0000647) | 1.90094646 |
| 132 | Premature loss of primary teeth (HP:0006323) | 1.89529414 |
| 133 | Leiomyosarcoma (HP:0100243) | 1.88865172 |
| 134 | Uterine leiomyosarcoma (HP:0002891) | 1.88865172 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87232515 |
| 136 | Mesangial abnormality (HP:0001966) | 1.86648613 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 1.86600510 |
| 138 | Atonic seizures (HP:0010819) | 1.86431380 |
| 139 | Aortic aneurysm (HP:0004942) | 1.86227270 |
| 140 | Absence seizures (HP:0002121) | 1.86136670 |
| 141 | Eczematoid dermatitis (HP:0000976) | 1.86034004 |
| 142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.85965322 |
| 143 | Mitochondrial inheritance (HP:0001427) | 1.85848587 |
| 144 | Abnormality of macrophages (HP:0004311) | 1.85845311 |
| 145 | Neoplasm of the heart (HP:0100544) | 1.85018383 |
| 146 | Inappropriate behavior (HP:0000719) | 1.84007165 |
| 147 | Abnormal biliary tract physiology (HP:0012439) | 1.82900853 |
| 148 | Bile duct proliferation (HP:0001408) | 1.82900853 |
| 149 | Absent frontal sinuses (HP:0002688) | 1.82419156 |
| 150 | Abnormality of vision evoked potentials (HP:0000649) | 1.81075561 |
| 151 | Progressive sensorineural hearing impairment (HP:0000408) | 1.81010688 |
| 152 | Abnormal urine output (HP:0012590) | 1.80968683 |
| 153 | Dyskinesia (HP:0100660) | 1.80202400 |
| 154 | Progressive hearing impairment (HP:0001730) | 1.79961865 |
| 155 | Optic disc pallor (HP:0000543) | 1.79730504 |
| 156 | Polygenic inheritance (HP:0010982) | 1.79471170 |
| 157 | Genital tract atresia (HP:0001827) | 1.79373831 |
| 158 | Male pseudohermaphroditism (HP:0000037) | 1.79237147 |
| 159 | Slow saccadic eye movements (HP:0000514) | 1.78135556 |
| 160 | Abnormality of alanine metabolism (HP:0010916) | 1.77630705 |
| 161 | Hyperalaninemia (HP:0003348) | 1.77630705 |
| 162 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77630705 |
| 163 | Drooling (HP:0002307) | 1.77424981 |
| 164 | Excessive salivation (HP:0003781) | 1.77424981 |
| 165 | Anencephaly (HP:0002323) | 1.76103514 |
| 166 | Recurrent bronchitis (HP:0002837) | 1.75623236 |
| 167 | Constricted visual fields (HP:0001133) | 1.75549321 |
| 168 | Poor eye contact (HP:0000817) | 1.75389541 |
| 169 | Turricephaly (HP:0000262) | 1.75264948 |
| 170 | Retinitis pigmentosa (HP:0000510) | 1.75240275 |
| 171 | Pointed chin (HP:0000307) | 1.75228094 |
| 172 | Male infertility (HP:0003251) | 1.75054205 |
| 173 | Anterior segment dysgenesis (HP:0007700) | 1.73878109 |
| 174 | Bladder carcinoma (HP:0002862) | 1.73805531 |
| 175 | Bladder neoplasm (HP:0009725) | 1.73805531 |
| 176 | Diminished motivation (HP:0000745) | 1.73658512 |
| 177 | Hepatocellular necrosis (HP:0001404) | 1.73310218 |
| 178 | Tachypnea (HP:0002789) | 1.73267031 |
| 179 | Achilles tendon contracture (HP:0001771) | 1.72868605 |
| 180 | Increased CSF lactate (HP:0002490) | 1.72251363 |
| 181 | Optic nerve hypoplasia (HP:0000609) | 1.71582588 |
| 182 | Severe visual impairment (HP:0001141) | 1.71430569 |
| 183 | Abnormality of macular pigmentation (HP:0008002) | 1.71320281 |
| 184 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69765290 |
| 185 | Bulbous nose (HP:0000414) | 1.68586308 |
| 186 | Optic neuritis (HP:0100653) | 1.67810667 |
| 187 | Retrobulbar optic neuritis (HP:0100654) | 1.67810667 |
| 188 | Abnormal eating behavior (HP:0100738) | 1.65225166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.71272195 |
| 2 | NTRK3 | 3.76526475 |
| 3 | FES | 3.32194223 |
| 4 | MAP3K6 | 2.88869112 |
| 5 | ADRBK2 | 2.85249039 |
| 6 | RIPK4 | 2.72259174 |
| 7 | MAP3K13 | 2.71973839 |
| 8 | BMPR1B | 2.36626898 |
| 9 | NUAK1 | 2.31458955 |
| 10 | MAP3K9 | 2.26171931 |
| 11 | MAP4K2 | 2.19284057 |
| 12 | TAOK3 | 2.17284263 |
| 13 | TAOK1 | 2.16701088 |
| 14 | GRK1 | 2.11563018 |
| 15 | MAPK13 | 2.09117148 |
| 16 | WNK3 | 2.08492226 |
| 17 | ACVR1B | 2.02207719 |
| 18 | CDK12 | 1.95460866 |
| 19 | WNK4 | 1.90143997 |
| 20 | MAP3K4 | 1.89686795 |
| 21 | KSR2 | 1.89079870 |
| 22 | CAMKK2 | 1.72241912 |
| 23 | FER | 1.72109912 |
| 24 | TTN | 1.71241370 |
| 25 | DAPK2 | 1.68622494 |
| 26 | PAK6 | 1.65941087 |
| 27 | LATS1 | 1.63444087 |
| 28 | CASK | 1.63070487 |
| 29 | CAMKK1 | 1.62784860 |
| 30 | MAP2K7 | 1.61824875 |
| 31 | GRK7 | 1.60209131 |
| 32 | INSRR | 1.55923423 |
| 33 | TLK1 | 1.54389182 |
| 34 | STK38 | 1.49452102 |
| 35 | MAP3K2 | 1.47097370 |
| 36 | CAMK1D | 1.45242630 |
| 37 | DMPK | 1.41479335 |
| 38 | NTRK2 | 1.36966957 |
| 39 | MAP2K4 | 1.31256555 |
| 40 | RAF1 | 1.28321566 |
| 41 | EEF2K | 1.26906805 |
| 42 | ADRBK1 | 1.25444769 |
| 43 | MOS | 1.23939445 |
| 44 | MAP4K1 | 1.23665352 |
| 45 | PAK3 | 1.20192217 |
| 46 | MAP3K5 | 1.18988548 |
| 47 | TNIK | 1.18076962 |
| 48 | TXK | 1.17310859 |
| 49 | LATS2 | 1.11794019 |
| 50 | TGFBR2 | 1.11366865 |
| 51 | ERN1 | 1.10832771 |
| 52 | MAP3K11 | 1.07140371 |
| 53 | ABL2 | 1.06992826 |
| 54 | CAMK1 | 1.02630757 |
| 55 | GRK5 | 1.02128274 |
| 56 | PTK2B | 1.01457981 |
| 57 | MAP3K14 | 1.01218148 |
| 58 | PRKCG | 0.98841462 |
| 59 | BMPR2 | 0.97031972 |
| 60 | CDK5 | 0.92253559 |
| 61 | MINK1 | 0.90679950 |
| 62 | SYK | 0.90388245 |
| 63 | PRKD2 | 0.90238529 |
| 64 | MAPK15 | 0.89806137 |
| 65 | RET | 0.89578976 |
| 66 | IRAK4 | 0.89413060 |
| 67 | PTK6 | 0.89391934 |
| 68 | LMTK2 | 0.89180820 |
| 69 | RPS6KA2 | 0.87472306 |
| 70 | MATK | 0.87299974 |
| 71 | SIK2 | 0.87118216 |
| 72 | NTRK1 | 0.86321486 |
| 73 | IRAK1 | 0.85984163 |
| 74 | BCKDK | 0.85816923 |
| 75 | EPHA3 | 0.84319716 |
| 76 | DYRK2 | 0.84130732 |
| 77 | HCK | 0.83275382 |
| 78 | ARAF | 0.82994898 |
| 79 | PDGFRB | 0.82571171 |
| 80 | KSR1 | 0.79109102 |
| 81 | MARK2 | 0.78134776 |
| 82 | CAMK1G | 0.77753097 |
| 83 | BLK | 0.77710595 |
| 84 | PRKCQ | 0.76643007 |
| 85 | SGK1 | 0.75051366 |
| 86 | PIK3CG | 0.74902485 |
| 87 | RIPK1 | 0.73245364 |
| 88 | MAP3K3 | 0.73103130 |
| 89 | TGFBR1 | 0.72514110 |
| 90 | SGK2 | 0.72070275 |
| 91 | TNK2 | 0.70734463 |
| 92 | MAP2K6 | 0.69712383 |
| 93 | CSNK1G2 | 0.69399934 |
| 94 | STK39 | 0.69371413 |
| 95 | SGK3 | 0.69165463 |
| 96 | MKNK2 | 0.67718779 |
| 97 | PRKCI | 0.65326675 |
| 98 | MAPKAPK3 | 0.64866977 |
| 99 | IRAK2 | 0.64417193 |
| 100 | JAK2 | 0.64254137 |
| 101 | CSNK1A1L | 0.63170328 |
| 102 | MST1R | 0.62946507 |
| 103 | TYRO3 | 0.62016167 |
| 104 | TRPM7 | 0.61760098 |
| 105 | CHUK | 0.61524726 |
| 106 | IRAK3 | 0.61151702 |
| 107 | STK16 | 0.60857709 |
| 108 | SGK223 | 0.60436113 |
| 109 | SGK494 | 0.60436113 |
| 110 | LYN | 0.59598017 |
| 111 | MAP3K7 | 0.59477652 |
| 112 | CSK | 0.59433301 |
| 113 | CSNK1G3 | 0.59246257 |
| 114 | ERBB4 | 0.59232479 |
| 115 | AKT3 | 0.56298114 |
| 116 | JAK1 | 0.55585447 |
| 117 | ZAK | 0.55399643 |
| 118 | IKBKE | 0.54489727 |
| 119 | DYRK3 | 0.54272933 |
| 120 | PRKD3 | 0.54137201 |
| 121 | MARK1 | 0.53303676 |
| 122 | FGR | 0.51771555 |
| 123 | PRKCZ | 0.51734065 |
| 124 | CDC42BPA | 0.51454485 |
| 125 | DDR2 | 0.50980391 |
| 126 | PLK2 | 0.50485955 |
| 127 | PKN1 | 0.50308856 |
| 128 | TBK1 | 0.49544345 |
| 129 | TEC | 0.49103471 |
| 130 | STK10 | 0.49023150 |
| 131 | VRK2 | 0.48508656 |
| 132 | CSNK1G1 | 0.47969076 |
| 133 | PDK1 | 0.47699086 |
| 134 | TIE1 | 0.47486100 |
| 135 | ITK | 0.47195330 |
| 136 | CAMK2B | 0.46752118 |
| 137 | OXSR1 | 0.45210360 |
| 138 | PRKCH | 0.45108764 |
| 139 | CAMK2D | 0.44951045 |
| 140 | PRKG1 | 0.44196936 |
| 141 | FRK | 0.44100950 |
| 142 | LCK | 0.43374101 |
| 143 | PRKACA | 0.43213935 |
| 144 | PINK1 | 0.42629777 |
| 145 | CAMK4 | 0.42517028 |
| 146 | FYN | 0.41965495 |
| 147 | BRAF | 0.39742270 |
| 148 | MAP3K1 | 0.39692980 |
| 149 | FGFR2 | 0.39484504 |
| 150 | CDK19 | 0.39374528 |
| 151 | RPS6KA3 | 0.38939442 |
| 152 | PDPK1 | 0.38611585 |
| 153 | CSF1R | 0.38484449 |
| 154 | MELK | 0.38044170 |
| 155 | CAMK2A | 0.37781298 |
| 156 | TRIB3 | 0.37731040 |
| 157 | NME1 | 0.37610796 |
| 158 | ERBB2 | 0.36412401 |
| 159 | DAPK3 | 0.35973136 |
| 160 | ABL1 | 0.35821063 |
| 161 | MAPK10 | 0.34154658 |
| 162 | IKBKB | 0.32625727 |
| 163 | STK11 | 0.31840345 |
| 164 | DAPK1 | 0.31277853 |
| 165 | PRKCE | 0.30134365 |
| 166 | KIT | 0.28803504 |
| 167 | RPS6KB1 | 0.28351478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.80751885 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63935955 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.60891592 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.49253877 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.40039661 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37558789 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.28150544 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.21684073 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12177740 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94448041 |
| 11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.94034810 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92164126 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.89958546 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.88588566 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.87207679 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.85825606 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.84566633 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84027078 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.83553875 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.82418355 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72393120 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.68258631 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67556803 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.64412753 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62325165 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60933902 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55688821 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54517900 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.51663811 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.46953372 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46100541 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.44650408 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43220208 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40903134 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.39376766 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39030227 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36724771 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35866642 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32891585 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31063908 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30517155 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29702043 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27157671 |
| 44 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24653813 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24614217 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23632493 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.22334133 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.22079082 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21898285 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.20653189 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20063792 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19858003 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.18752064 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 1.17447107 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11042679 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10606108 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09619665 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08546687 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08357473 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06521821 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 1.05984193 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04848634 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04215242 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04097338 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03672389 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02161424 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01423722 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01092389 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00805516 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.99268874 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.99217275 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98648751 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98154257 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98121007 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.97312656 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97269196 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97014864 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96581206 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.95852889 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95757145 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95609440 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94465632 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94423268 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94413116 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94328973 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92677657 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90000990 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.88810827 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88255184 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88202402 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87630081 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87206154 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84087848 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.84081672 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82811275 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82641715 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81752495 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.81244047 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80313472 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80287904 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79575720 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79066242 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77491549 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77353562 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76822763 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75892333 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75404492 |
| 108 | RNA polymerase_Homo sapiens_hsa03020 | 0.74605761 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74042660 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73906579 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.73661448 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73398143 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72313328 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71394072 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70553645 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69669818 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69509240 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.68322388 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.67778302 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67734787 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67548540 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.66851674 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66829261 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65966277 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65380686 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65013682 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64889556 |
| 128 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64822789 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64367133 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64166048 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63875921 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61764312 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61489616 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.60942346 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60915987 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60724580 |
| 137 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60303204 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59980635 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59683788 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56984692 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.56538338 |
| 142 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55947488 |
| 143 | Axon guidance_Homo sapiens_hsa04360 | 0.55656168 |
| 144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54933311 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.54228968 |
| 146 | Influenza A_Homo sapiens_hsa05164 | 0.53982086 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53752815 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53726470 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.53634156 |
| 150 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53439918 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52666552 |
| 152 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48963391 |
| 153 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48519782 |
| 154 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46503031 |
| 155 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39965594 |
| 156 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38943635 |
| 157 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36298856 |
| 158 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33391417 |

